-+ 0.00%
-+ 0.00%
-+ 0.00%

SCHOTT Pharma updates SBTi-validated climate targets, sets 27.5% Scope 3 cut by 2030

PUBT·08/17/2026 15:32:58
Listen to the news
SCHOTT Pharma updates SBTi-validated climate targets, sets 27.5% Scope 3 cut by 2030
  • SCHOTT Pharma aligned its climate plan with SCHOTT Group targets validated by SBTi, shifting focus toward measurable value-chain emissions cuts.
  • Targets retain a 46.2% absolute reduction in Scope 1 and 2 GHG emissions by fiscal 2030 versus a 2019 baseline.
  • New Scope 3 goal commits to a 27.5% absolute cut by fiscal 2030 in the highest-impact categories.
  • Previous internal “climate neutral by 2030” goal was dropped, reflecting a move away from Scope 1 and 2 compensation-led neutrality.
  • Decarbonization actions include renewable Energy Attribute Certificates since 2021, efficiency upgrades, technology changes, supplier engagement.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Schott Pharma AG & Co. KGaA published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2384288_en) on August 17, 2026, and is solely responsible for the information contained therein.